Harbor Light Capital Partners

Carmell Therapeutics Corporation, founded in 2007 and based in Pittsburgh, Pennsylvania, specializes in the production of plasma-based biologically-active plastic medical devices designed for the treatment of bone and connective tissue injuries. The company utilizes proprietary technology developed in collaboration with Carnegie Mellon University and Allegheny General Hospital to manufacture these sterile, off-the-shelf products. Their offerings include REPAIR bone putty, which is used to fill bone defects, and a surgical scaffold that facilitates the healing of injured tendons and ligaments. These products are engineered to promote tissue healing by leveraging the body’s own growth and regenerative factors, ensuring favorable mechanical properties that align with the repaired tissue. Carmell Therapeutics primarily targets the sports medicine market, aiming to enhance clinical outcomes for patients with connective tissue injuries.

Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, that specializes in genetic testing services. The company offers a range of clinical tests aimed at diagnosing developmental delays, intellectual disabilities, autism spectrum disorders, epilepsy, seizure disorders, and mitochondrial disorders. Its testing portfolio includes comprehensive genetic analyses, targeted disease-specific panels, and next-generation sequencing services. Key offerings include the epiSEEK tests for neurological function and seizure disorders, the devSEEK panel for neurodevelopmental disorders, mtSEEK for mitochondrial genome sequencing, and various other specialized panels. Additionally, Courtagen provides next-generation sequencing solutions to researchers in academia, pharmaceuticals, and biotechnology, supporting drug development and clinical trials. Founded in 2003, the company has evolved from its previous identity as Avantra Biosciences Corporation to focus on enhancing diagnostic capabilities for patients with neurological conditions.

Senet, Inc. specializes in providing Internet of Things (IoT) connectivity solutions through a scalable low power wide area network (LoRaWAN) infrastructure. Founded in 2006 and based in Portsmouth, New Hampshire, the company offers a range of services including network planning and management, consulting, and developer portal services. Senet's cloud-based managed network services facilitate long-distance sensor connectivity, enabling businesses to efficiently monitor and manage distributed assets. Its offerings support various applications such as residential fuel oil and propane tank automation, water and gas metering, and commercial lubrication distribution. By providing cost-effective solutions, Senet empowers enterprises to leverage data-driven insights in the rapidly evolving Machine-to-Machine (M2M) IoT landscape.

Carmell Therapeutics Corporation, founded in 2007 and based in Pittsburgh, Pennsylvania, specializes in the production of plasma-based biologically-active plastic medical devices designed for the treatment of bone and connective tissue injuries. The company utilizes proprietary technology developed in collaboration with Carnegie Mellon University and Allegheny General Hospital to manufacture these sterile, off-the-shelf products. Their offerings include REPAIR bone putty, which is used to fill bone defects, and a surgical scaffold that facilitates the healing of injured tendons and ligaments. These products are engineered to promote tissue healing by leveraging the body’s own growth and regenerative factors, ensuring favorable mechanical properties that align with the repaired tissue. Carmell Therapeutics primarily targets the sports medicine market, aiming to enhance clinical outcomes for patients with connective tissue injuries.

Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain. It addresses the unmet needs in the treatment of chronic neuropathological conditions. For many neurologic conditions, there are identified molecular targets, but the blood-brain barrier prevents drugs from addressing those targets from reaching diseased brain regions in a controlled and targeted manner. In addition, there is a fundamental need for control and precision in molecular therapy to the CNS. The company is transforming disease-modifying therapies for rare and orphan disorders through Advanced Precision Delivery Platforms.

Headquartered in Boston, Terascala is the fast data company. Terascala storage appliances dramatically accelerate the time to insight for organizations that rely on simulation, analysis, and modeling tools to bring new products and innovation to market. Exclusively available through strategic partners Dell, EMC, and NetApp, Terascala storage appliances provide on-demand throughput at multiple gigabytes per second while leveraging industry-leading storage platforms for long-term data protection.

EnerTrac saves fuel and reduces emissions by automating the measuring and monitoring processes of devices that have historically required manual reading and recording. EnerTrac innovative low frequency and low cost monitoring and communications network provides delivery companies with actionable data that makes their delivery schedules more targeted and more efficient. EnerTrac technology facilitates machine to machine (M-2-M) communication and is currently being used to automate the monitoring of fuel oil and propane fuel tanks. The network that EnerTrac is establishing could ultimately be extended to monitor thermostats, flow meters, heating, ventilation and air conditioning systems.

For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.

Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, that specializes in genetic testing services. The company offers a range of clinical tests aimed at diagnosing developmental delays, intellectual disabilities, autism spectrum disorders, epilepsy, seizure disorders, and mitochondrial disorders. Its testing portfolio includes comprehensive genetic analyses, targeted disease-specific panels, and next-generation sequencing services. Key offerings include the epiSEEK tests for neurological function and seizure disorders, the devSEEK panel for neurodevelopmental disorders, mtSEEK for mitochondrial genome sequencing, and various other specialized panels. Additionally, Courtagen provides next-generation sequencing solutions to researchers in academia, pharmaceuticals, and biotechnology, supporting drug development and clinical trials. Founded in 2003, the company has evolved from its previous identity as Avantra Biosciences Corporation to focus on enhancing diagnostic capabilities for patients with neurological conditions.

For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.

Carmell Therapeutics Corporation, founded in 2007 and based in Pittsburgh, Pennsylvania, specializes in the production of plasma-based biologically-active plastic medical devices designed for the treatment of bone and connective tissue injuries. The company utilizes proprietary technology developed in collaboration with Carnegie Mellon University and Allegheny General Hospital to manufacture these sterile, off-the-shelf products. Their offerings include REPAIR bone putty, which is used to fill bone defects, and a surgical scaffold that facilitates the healing of injured tendons and ligaments. These products are engineered to promote tissue healing by leveraging the body’s own growth and regenerative factors, ensuring favorable mechanical properties that align with the repaired tissue. Carmell Therapeutics primarily targets the sports medicine market, aiming to enhance clinical outcomes for patients with connective tissue injuries.

Micronotes is an AI-enabled cloud-based marketing automation company serving financial service providers. The company’s fast, automated and cloud-based digital interview platform applies machine learning to customer data to improve customer engagement and effectively cross-sell financial services through the digital service channels. We are headquartered in Boston, MA at the Cambridge Innovative Center (CIC).

Eggrock Partners, Inc. operates as a consulting and systems integration company that focuses on delivering e-business solutions to emerging enterprises. The company is based in Concord, Massachusetts. As of March 31, 2000, Eggrock Partners, L.L.C. is a subsidiary of Breakaway Solutions, Inc.

[FetchDog](http://www.fetchdog.com) is a website for dog owners.

For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.